debate: which is the optimal approach for cll? - br
Published 10 years ago • 76 plays • Length 12:08Download video MP4
Download video MP3
Similar videos
-
14:21
debate: which is the optimal approach for cll? - fcr
-
13:55
debate: optimal approach for the management of cll patients with del(17p) - novel agents
-
15:23
debate: optimal approach for the management of cll patients with del(17p) - ibrutinib
-
21:05
cll: optimal approaches for patients with deletion 17p
-
14:29
debate: what is the best approach for relapsed t cell lymphoma? - allosct
-
13:19
ighv and tp53 sequencing: clinical utility in chronic lymphocytic leukemia (cll)
-
1:00:05
chronic lymphocytic leukemia (cll): what it is when to treat and what’s ahead
-
1:33:30
living with chronic lymphocytic leukemia (cll)
-
11:23
debate: best approach for multiple relapsed cll after chemoimmunotherapy - kinase inhibitor
-
14:03
debate: best approach for multiple relapsed cll after chemoimmunotherapy - asct
-
1:00:19
the molecular twin platform: a multi-omic approach for predicting accurate clinical outcomes
-
14:02
debate: best frontline regimen for a cll patient aged 60 who requires therapy - fcr
-
19:14
debate: best approach for multiple relapsed cll after chemoimmunotherapy - other novel agents
-
14:46
debate: optimal approach for stage i nsclc - surgery
-
12:34
debate: is it appropriate to treat patients with cll earlier in the era of novel agents? - no
-
15:02
debate: will novel-agent based combination therapy become standard of care for cll? - no
-
14:48
debate: best frontline regimen for a cll patient aged 60 who requires therapy - ibrutinib
-
19:42
treatment options for the young cll patient with deletion 17p: do they need a different approach?
-
21:19
cll: sequencing monotherapy vs. combination therapy
-
20:21
novel agents in elderly cll patients: should the approach be different?
-
13:34
debate: what is the treatment choice for waldenstrom macroglobulinemia? - bendamustine
-
24:17
combination of novel agents in cll: is this the final answer?